BioLargo, Inc
(OTC BB: BLGO)
Dennis Calvert, CEO

BioLargo, Inc. is engaged in pre-licensing and product evaluation with strategic partners to leverage a suite of patented and patent-pending intellectual property, the BioLargo technology. The BioLargo technology, the centerpiece of which is CupriDyne, works by combining minerals and salts with water from any source to generate and deliver molecular iodine on demand, in controlled dosages, in order to balance efficacy of disinfectant performance with concerns about toxicity. In addition to its BioLargo technology, the Company acquired the rights to market an iodine based water disinfection system (the Isan system) from Ioteq IP Pty. Ltd., an Australian company, and its United States affiliate Ioteq Inc. during the year ended December 31, 2008. The Isan system is an automated water disinfection system that substantially reduces the incidence of fungal growth, spoilage, organisms and pathogens in water and on food.